Rezolute Inc (RZLT)

NASDAQ · Health Care

$3.95 -4.13% Close Oct 30, 2026 Live

Rezolute stock today

Rezolute closed at $3.95 on October 30, 2026, down 4.13% on the day. Over the past year it returned -59.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $380 million.

$5.00$10.00
NovJan 2026MarMayJulSep
Total return with dividends reinvested, to the close on Oct 30, 2026
PeriodRZLTS&P 500 (SPY)
1 month-4.6%-0.9%
3 months-19.1%+2.1%
Year to date+67.4%+11.7%
1 year-59.8%+12.4%
3 years+276.2%+88.5%
5 years-38.3%+76.0%

Key statistics

Market value
$380M
52-week range
$1.40 to $10.94
Next report
Nov 5, 2026 (estimated)

About Rezolute

Develops therapeutic drugs for metabolic and endocrine disorders.

Sector: Health Care

More on Rezolute

No forecast, no recommendation. This page describes Rezolute Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.